{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:36:34Z","timestamp":1794105394032,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glaucoma is a progressive chronic retinal degenerative disease and a leading cause of global irreversible blindness. This disease is characterized by optic nerve damage and retinal ganglion cell (RGC) death. The current treatments available target the lowering of intraocular pressure (IOP), the main risk factor for disease onset and development. However, in some patients, vision loss progresses despite successful IOP control, indicating that new and effective treatments are needed, such as those targeting the neuroprotection of RGCs. Adenosine A<jats:sub>3<\/jats:sub> receptor (A<jats:sub>3<\/jats:sub>R) activation confers protection to RGCs following an excitotoxic stimulus. In this work, we investigated whether the activation of A<jats:sub>3<\/jats:sub>R could also afford protection to RGCs in the laser-induced ocular hypertension (OHT) model, a well-characterized animal model of glaucoma. The intravitreal injection of 2-Cl-IB-MECA, a selective A<jats:sub>3<\/jats:sub>R agonist, abolished the alterations induced by OHT in the negative and positive components of scotopic threshold response (STR) without changing a- and b-wave amplitudes both in scotopic and photopic conditions. Moreover, the treatment of OHT eyes with the A<jats:sub>3<\/jats:sub>R agonist promoted the survival of RGCs, attenuated the impairment in retrograde axonal transport, and improved the structure of the optic nerve. Taking into consideration the beneficial effects afforded by 2-Cl-IB-MECA, we can envisage that A<jats:sub>3<\/jats:sub>R activation can be considered a good therapeutic strategy to protect RGCs from glaucomatous damage.<\/jats:p>","DOI":"10.1038\/s41419-020-2593-y","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T06:02:36Z","timestamp":1590559356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Activation of adenosine A3 receptor protects retinal ganglion cells from degeneration induced by ocular hypertension"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0479-3066","authenticated-orcid":false,"given":"Raquel","family":"Boia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Salinas-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Gallego-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"Galindo-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas D.","family":"Aires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8566-9277","authenticated-orcid":false,"given":"Marta","family":"Agudo-Barriuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio Francisco","family":"Ambr\u00f3sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Vidal-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-7041","authenticated-orcid":false,"given":"Ana Raquel","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"2593_CR1","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman, S. R. et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob. Health 5, e1221\u2013e1234 (2017).","journal-title":"Lancet Glob. Health"},{"key":"2593_CR2","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/ijms21072262","volume":"21","author":"R Boia","year":"2020","unstructured":"Boia, R. et al. Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead. Int. J. Mol. Sci. 21, 2262\u20132300 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2593_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ohc.2005.04.002","volume":"18","author":"MH Kuehn","year":"2005","unstructured":"Kuehn, M. H., Fingert, J. H. & Kwon, Y. H. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol. Clin. North Am. 18, 383\u2013395 (2005).","journal-title":"Ophthalmol. Clin. North Am."},{"key":"2593_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske, M. C. et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121, 48\u201356 (2003).","journal-title":"Arch. Ophthalmol."},{"key":"2593_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/ICU.0b013e3282f3919b","volume":"19","author":"MB Shields","year":"2008","unstructured":"Shields, M. B. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr. Opin. Ophthalmol. 19, 85\u201388 (2008).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"2593_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0161-6420(00)00518-2","volume":"108","author":"DR Anderson","year":"2001","unstructured":"Anderson, D. R., Drance, S. M. & Schulzer, M., Collaborative Normal-Tension Glaucoma Study, G. Natural history of normal-tension glaucoma. Ophthalmology 108, 247\u2013253 (2001).","journal-title":"Ophthalmology"},{"key":"2593_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.ajo.2011.06.015","volume":"152","author":"MF Cordeiro","year":"2011","unstructured":"Cordeiro, M. F. & Levin, L. A. Clinical evidence for neuroprotection in glaucoma. Am. J. Ophthalmol. 152, 715\u2013716 (2011).","journal-title":"Am. J. Ophthalmol."},{"key":"2593_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F. & Varani, K. Pharmacology of adenosine receptors: the state of the art. Physiol. Rev. 98, 1591\u20131625 (2018).","journal-title":"Physiol. Rev."},{"key":"2593_CR9","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1002\/jnr.21071","volume":"84","author":"GJ Chen","year":"2006","unstructured":"Chen, G. J. et al. Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J. Neurosci. Res. 84, 1848\u20131855 (2006).","journal-title":"J. Neurosci. Res."},{"key":"2593_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1471-4159.2006.03900.x","volume":"98","author":"X Zhang","year":"2006","unstructured":"Zhang, X., Zhang, M., Laties, A. M. & Mitchell, C. H. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation. J. Neurochem. 98, 566\u2013575 (2006).","journal-title":"J. Neurochem."},{"key":"2593_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.exer.2010.06.017","volume":"91","author":"H Hu","year":"2010","unstructured":"Hu, H. et al. Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo. Exp. Eye Res. 91, 425\u2013432 (2010).","journal-title":"Exp. Eye Res."},{"key":"2593_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuint.2009.08.011","volume":"56","author":"M Zhang","year":"2010","unstructured":"Zhang, M. et al. The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cells. Neurochem. Int. 56, 35\u201341 (2010).","journal-title":"Neurochem. Int."},{"key":"2593_CR13","first-page":"937","volume":"12","author":"M Zhang","year":"2006","unstructured":"Zhang, M. et al. Identification of the A3 adenosine receptor in rat retinal ganglion cells. Mol. Vis. 12, 937\u2013948 (2006).","journal-title":"Mol. Vis."},{"key":"2593_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.exer.2015.08.009","volume":"140","author":"J Galvao","year":"2015","unstructured":"Galvao, J. et al. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration. Exp. Eye Res. 140, 65\u201374 (2015).","journal-title":"Exp. Eye Res."},{"key":"2593_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.exer.2009.10.003","volume":"90","author":"M Salinas-Navarro","year":"2010","unstructured":"Salinas-Navarro, M. et al. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 90, 168\u2013183 (2010).","journal-title":"Exp. Eye Res."},{"key":"2593_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep27532","volume":"6","author":"MH Madeira","year":"2016","unstructured":"Madeira, M. H. et al. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma. Sci. Rep. 6, 27532 (2016).","journal-title":"Sci. Rep."},{"key":"2593_CR17","first-page":"2578","volume":"15","author":"M Salinas-Navarro","year":"2009","unstructured":"Salinas-Navarro, M. et al. Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol. Vis. 15, 2578\u20132598 (2009).","journal-title":"Mol. Vis."},{"key":"2593_CR18","first-page":"2373","volume":"15","author":"L Alarcon-Martinez","year":"2009","unstructured":"Alarcon-Martinez, L. et al. Short and long term axotomy-induced ERG changes in albino and pigmented rats. Mol. Vis. 15, 2373\u20132383 (2009).","journal-title":"Mol. Vis."},{"key":"2593_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.451","volume":"8","author":"R Boia","year":"2017","unstructured":"Boia, R. et al. Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage. Cell Death Dis. 8, e3065 (2017).","journal-title":"Cell Death Dis."},{"key":"2593_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.visres.2008.09.029","volume":"49","author":"M Salinas-Navarro","year":"2009","unstructured":"Salinas-Navarro, M. et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vis. Res. 49, 115\u2013126 (2009).","journal-title":"Vis. Res."},{"key":"2593_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"2593_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.etp.2007.11.012","volume":"60","author":"SG Rosolen","year":"2008","unstructured":"Rosolen, S. G., Kolomiets, B., Varela, O. & Picaud, S. Retinal electrophysiology for toxicology studies: applications and limits of ERG in animals and ex vivo recordings. Exp. Toxicol. Pathol. 60, 17\u201332 (2008).","journal-title":"Exp. Toxicol. Pathol."},{"key":"2593_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2015.04.008","volume":"220","author":"M Vidal-Sanz","year":"2015","unstructured":"Vidal-Sanz, M. et al. Retinal neurodegeneration in experimental glaucoma. Prog. Brain Res. 220, 1\u201335 (2015).","journal-title":"Prog. Brain Res."},{"key":"2593_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.exer.2016.08.006","volume":"151","author":"B Mead","year":"2016","unstructured":"Mead, B. & Tomarev, S. Evaluating retinal ganglion cell loss and dysfunction. Exp. Eye Res. 151, 96\u2013106 (2016).","journal-title":"Exp. Eye Res."},{"key":"2593_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exer.2015.01.006","volume":"132","author":"A Ortin-Martinez","year":"2015","unstructured":"Ortin-Martinez, A. et al. Laser-induced ocular hypertension in adult rats does not affect non-RGC neurons in the ganglion cell layer but results in protracted severe loss of cone-photoreceptors. Exp. Eye Res. 132, 17\u201333 (2015).","journal-title":"Exp. Eye Res."},{"key":"2593_CR26","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1167\/iovs.08-3267","volume":"50","author":"FM Nadal-Nicolas","year":"2009","unstructured":"Nadal-Nicolas, F. M. et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest. Ophthalmol. Vis. Sci. 50, 3860\u20133868 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR27","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1167\/iovs.11-7869","volume":"52","author":"JM Kwong","year":"2011","unstructured":"Kwong, J. M., Quan, A., Kyung, H., Piri, N. & Caprioli, J. Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies. Invest. Ophthalmol. Vis. Sci. 52, 9694\u20139702 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR28","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1167\/iovs.09-4098","volume":"51","author":"JM Kwong","year":"2010","unstructured":"Kwong, J. M., Caprioli, J. & Piri, N. RNA binding protein with multiple splicing: a new marker for retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 51, 1052\u20131058 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR29","first-page":"774","volume":"36","author":"HA Quigley","year":"1995","unstructured":"Quigley, H. A. et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis. Sci. 36, 774\u2013786 (1995).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archopht.1997.01100160201010","volume":"115","author":"LA Kerrigan","year":"1997","unstructured":"Kerrigan, L. A., Zack, D. J., Quigley, H. A., Smith, S. D. & Pease, M. E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 115, 1031\u20131035 (1997).","journal-title":"Arch. Ophthalmol."},{"key":"2593_CR31","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1523\/JNEUROSCI.14-07-04368.1994","volume":"14","author":"M Berkelaar","year":"1994","unstructured":"Berkelaar, M., Clarke, D. B., Wang, Y. C., Bray, G. M. & Aguayo, A. J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14, 4368\u20134374 (1994).","journal-title":"J. Neurosci."},{"key":"2593_CR32","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3109\/02713683.2013.848902","volume":"39","author":"AL Georgiou","year":"2014","unstructured":"Georgiou, A. L., Guo, L., Francesca Cordeiro, M. & Salt, T. E. Electroretinogram and visual-evoked potential assessment of retinal and central visual function in a rat ocular hypertension model of glaucoma. Curr. Eye Res. 39, 472\u2013486 (2014).","journal-title":"Curr. Eye Res."},{"key":"2593_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.exer.2010.05.020","volume":"91","author":"N Cuenca","year":"2010","unstructured":"Cuenca, N. et al. Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice. Exp. Eye Res. 91, 273\u2013285 (2010).","journal-title":"Exp. Eye Res."},{"key":"2593_CR34","first-page":"2532","volume":"33","author":"S Panda","year":"1992","unstructured":"Panda, S. & Jonas, J. B. Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma. Invest. Ophthalmol. Vis. Sci. 33, 2532\u20132536 (1992).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/archopht.118.2.235","volume":"118","author":"TM Nork","year":"2000","unstructured":"Nork, T. M. et al. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch. Ophthalmol. 118, 235\u2013245 (2000).","journal-title":"Arch. Ophthalmol."},{"key":"2593_CR36","first-page":"1863","volume":"31","author":"K Holopigian","year":"1990","unstructured":"Holopigian, K., Seiple, W., Mayron, C., Koty, R. & Lorenzo, M. Electrophysiological and psychophysical flicker sensitivity in patients with primary open-angle glaucoma and ocular hypertension. Investi. Ophthalmol. Vis. Sci. 31, 1863\u20131868 (1990).","journal-title":"Investi. Ophthalmol. Vis. Sci."},{"key":"2593_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083733","volume":"8","author":"R de Hoz","year":"2013","unstructured":"de Hoz, R. et al. Rod-like microglia are restricted to eyes with laser-induced ocular hypertension but absent from the microglial changes in the contralateral untreated eye. PLoS ONE 8, e83733 (2013).","journal-title":"PLoS ONE"},{"key":"2593_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/glia.23579","volume":"67","author":"ID Aires","year":"2019","unstructured":"Aires, I. D. et al. Blockade of microglial adenosine A2A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells. Glia 67, 896\u2013914 (2019).","journal-title":"Glia"},{"key":"2593_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0982-7","volume":"14","author":"FM Nadal-Nicolas","year":"2017","unstructured":"Nadal-Nicolas, F. M. et al. Microglial dynamics after axotomy-induced retinal ganglion cell death. J. Neuroinflammation 14, 218 (2017).","journal-title":"J. Neuroinflammation"},{"key":"2593_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.preteyeres.2012.07.001","volume":"31","author":"DJ Calkins","year":"2012","unstructured":"Calkins, D. J. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retinal Eye Res. 31, 702\u2013719 (2012).","journal-title":"Prog. Retinal Eye Res."},{"key":"2593_CR41","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1167\/iovs.03-0138","volume":"44","author":"F Mabuchi","year":"2003","unstructured":"Mabuchi, F., Aihara, M., Mackey, M. R., Lindsey, J. D. & Weinreb, R. N. Optic nerve damage in experimental mouse ocular hypertension. Invest. Ophthalmol. Vis. Sci. 44, 4321\u20134330 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113011","volume":"9","author":"TE Choe","year":"2014","unstructured":"Choe, T. E., Abbott, C. J., Piper, C., Wang, L. & Fortune, B. Comparison of longitudinal in vivo measurements of retinal nerve fiber layer thickness and retinal ganglion cell density after optic nerve transection in rat. PLoS ONE 9, e113011 (2014).","journal-title":"PLoS ONE"},{"key":"2593_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-92","volume":"9","author":"BI Gallego","year":"2012","unstructured":"Gallego, B. I. et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J. Neuroinflammation 9, 92 (2012).","journal-title":"J. Neuroinflammation"},{"key":"2593_CR44","doi-asserted-by":"crossref","unstructured":"Lucas-Ruiz, F., Galindo-Romero, C., Rodriguez-Ramirez, K. T., Vidal-Sanz, M. & Agudo-Barriuso, M. Neuronal death in the contralateral un-injured retina after unilateral axotomy: role of microglial cells. Int. J. Mol. Sci. 20, 5733\u20135753 (2019).","DOI":"10.3390\/ijms20225733"},{"key":"2593_CR45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/WNR.0b013e32832027e6","volume":"20","author":"T Macharadze","year":"2009","unstructured":"Macharadze, T. et al. Interretinal transduction of injury signals after unilateral optic nerve crush. Neuroreport 20, 301\u2013305 (2009).","journal-title":"Neuroreport"},{"key":"2593_CR46","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3892\/mmr.2013.1413","volume":"7","author":"P Fishman","year":"2013","unstructured":"Fishman, P., Cohen, S. & Bar-Yehuda, S. Targeting the A3 adenosine receptor for glaucoma treatment (review). Mol. Med. Rep. 7, 1723\u20131725 (2013).","journal-title":"Mol. Med. Rep."},{"key":"2593_CR47","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ophtha.2009.11.029","volume":"117","author":"I Avni","year":"2010","unstructured":"Avni, I. et al. Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial. Ophthalmology 117, 1287\u20131293 (2010).","journal-title":"Ophthalmology"},{"key":"2593_CR48","first-page":"3021","volume":"43","author":"MY Avila","year":"2002","unstructured":"Avila, M. Y., Stone, R. A. & Civan, M. M. Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Invest. Ophthalmol. Vis. Sci. 43, 3021\u20133026 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.exer.2018.05.020","volume":"174","author":"KM Beach","year":"2018","unstructured":"Beach, K. M., Hung, L. F., Arumugam, B., Smith, E. L. 3rd & Ostrin, L. A. Adenosine receptor distribution in Rhesus monkey ocular tissue. Exp. Eye Res. 174, 40\u201350 (2018).","journal-title":"Exp. Eye Res."},{"key":"2593_CR50","doi-asserted-by":"publisher","first-page":"E001","DOI":"10.1017\/S0952523816000171","volume":"34","author":"G Jonsson","year":"2017","unstructured":"Jonsson, G. & Eysteinsson, T. Retinal A2A and A3 adenosine receptors modulate the components of the rat electroretinogram. Vis. Neurosci. 34, E001 (2017).","journal-title":"Vis. Neurosci."},{"key":"2593_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3129\/can j ophthalmol.i07-036","volume":"42","author":"RW Nickells","year":"2007","unstructured":"Nickells, R. W. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can. J. Ophthalmol. 42, 278\u2013287 (2007).","journal-title":"Can. J. Ophthalmol."},{"key":"2593_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.exer.2018.02.019","volume":"170","author":"KI Nakashima","year":"2018","unstructured":"Nakashima, K. I. et al. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells. Exp. Eye Res. 170, 160\u2013168 (2018).","journal-title":"Exp. Eye Res."},{"key":"2593_CR53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0955-0674(93)90015-I","volume":"5","author":"M Wegner","year":"1993","unstructured":"Wegner, M., Drolet, D. W. & Rosenfeld, M. G. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 5, 488\u2013498 (1993).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2593_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049830","volume":"7","author":"FM Nadal-Nicolas","year":"2012","unstructured":"Nadal-Nicolas, F. M. et al. Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS ONE 7, e49830 (2012).","journal-title":"PLoS ONE"},{"key":"2593_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1167\/iovs.15-17841","volume":"57","author":"MC Sanchez-Migallon","year":"2016","unstructured":"Sanchez-Migallon, M. C., Valiente-Soriano, F. J., Nadal-Nicolas, F. M., Vidal-Sanz, M. & Agudo-Barriuso, M. Apoptotic retinal ganglion cell death after optic nerve transection or crush in mice: delayed RGC loss with BDNF or a caspase 3 inhibitor. Invest. Ophthalmol. Vis. Sci. 57, 81\u201393 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110612","volume":"9","author":"B Mead","year":"2014","unstructured":"Mead, B. et al. Comparative evaluation of methods for estimating retinal ganglion cell loss in retinal sections and wholemounts. PLoS ONE 9, e110612 (2014).","journal-title":"PLoS ONE"},{"key":"2593_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1167\/iovs.08-2321","volume":"50","author":"RM Sappington","year":"2009","unstructured":"Sappington, R. M., Sidorova, T., Long, D. J. & Calkins, D. J. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest. Ophthalmol. Vis. Sci. 50, 717\u2013728 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2593_CR58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","volume":"21","author":"KM Sampat","year":"2010","unstructured":"Sampat, K. M. & Garg, S. J. Complications of intravitreal injections. Curr. Opin. Ophthalmol. 21, 178\u2013183 (2010).","journal-title":"Curr. Opin. Ophthalmol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2593-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2593-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2593-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:57:53Z","timestamp":1670252273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2593-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2593"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2593-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"401"}}